Switch to:
More From Other Websites
CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue Sarcomas at the 2017... Apr 21 2017
CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up Apr 20 2017
ETFs with exposure to CytRx Corp. : April 20, 2017 Apr 20 2017
Blog Coverage CytRx Announces FDA's Approval for New Drug Application Apr 20 2017
CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue... Apr 19 2017
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1 Apr 11 2017
CytRx Corp. :CYTR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Mar 21 2017
CytRx Reports 2016 Financial Results Mar 15 2017
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
CytRx to Present at the 29th Annual ROTH Conference Mar 07 2017
CytRx to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017
CytRx Granted Type B Pre-NDA Meeting with U.S. FDA for Registration Pathway with Aldoxorubicin as a... Jan 04 2017
Is the Options Market Predicting a Spike in CytRx Corp (CYTR) Stock? Dec 30 2016
CytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer Dec 19 2016
How CytRx Corporation (CYTR) Stacks Up Against Its Peers Dec 14 2016
CytRx Corporation Announces $8.1 Million Registered Direct Offering of Common Stock Dec 13 2016
Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx Board of Directors Dec 02 2016
CytRx CEO Pockets Millions of Dollars as Failed Sarcoma Drug Moves to FDA Nov 29 2016
CytRx Reports Statistically Significant Updated Results from Pivotal Phase 3 Trial of Aldoxorubicin... Nov 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK